Short-Acting Insulin Market is segmented By Type (Insulin Lispro, Insulin Aspart, Insulin Glulisine), By Indication (Type 1 Diabetes, Type 2 Diabetes), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.
The major players operating in the short-acting insulin market include Novo Nordisk, Sanofi, Eli Lilly and Company, Biocon and Adocia.
Short-Acting Insulin Market